John H. Mills
#167,724
Most Influential Person Now
John H. Mills's AcademicInfluence.com Rankings
John H. Millsbiology Degrees
Biology
#13693
World Rank
#17248
Historical Rank
Computational Biology
#321
World Rank
#322
Historical Rank
Virology
#343
World Rank
#350
Historical Rank
Molecular Biology
#2336
World Rank
#2371
Historical Rank
Download Badge
Biology
John H. Mills's Degrees
- PhD Molecular Biology University of California, Berkeley
- Masters Biochemistry Stanford University
Why Is John H. Mills Influential?
(Suggest an Edit or Addition)John H. Mills's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients (1995) (1246)
- Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. (1984) (638)
- Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. (1988) (509)
- Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. (1989) (435)
- Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. (1999) (358)
- ISOLATION OF AIDS-ASSOCIATED RETROVIRUSES FROM CEREBROSPINAL FLUID AND BRAIN OF PATIENTS WITH NEUROLOGICAL SYMPTOMS (1985) (346)
- Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. (1990) (312)
- Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. (1990) (306)
- Interferon therapy for condylomata acuminata. (1986) (242)
- Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes (1996) (237)
- Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. (1971) (214)
- Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. (1991) (195)
- Pulmonary infectious complications of human immunodeficiency virus infection. Part II. (1990) (178)
- Pulmonary infectious complications of human immunodeficiency virus infection. Part I. (1990) (164)
- Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. (1988) (161)
- Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. (1987) (157)
- Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. (1987) (153)
- Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. (1986) (148)
- Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. (1986) (144)
- Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity (1996) (140)
- Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. (1989) (139)
- Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome (1989) (138)
- Influence of immunological factors in respiratory syncytial virus disease. (1970) (133)
- Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. (2002) (129)
- Human Immunodeficiency Virus Type 1 Nef Binds to Tumor Suppressor p53 and Protects Cells against p53-Mediated Apoptosis (2002) (128)
- Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. (1999) (128)
- NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. (1987) (125)
- Kucers' the use of antibiotics : a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs (2017) (122)
- Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. (1990) (114)
- Heart failure in infective endocarditis: predisposing factors, course, and treatment. (1974) (114)
- Temperature-sensitive mutants of influenza virus. VI. Transfer of TS lesions from the Asian subtype of influenza A virus (H2N2) to the Hong Kong subtype (H3N2). (1975) (99)
- Mechanisms of platelet aggregation by viridans group streptococci (1987) (96)
- Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy. (1988) (95)
- Association of Respiratory Syncytial Virus M Protein with Viral Nucleocapsids Is Mediated by the M2-1 Protein (2008) (92)
- The matrix protein of Human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription (2003) (92)
- Acyclovir prevents reactivation of herpes simplex labialis in skiers. (1988) (90)
- Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals. (1971) (90)
- Human pharmacokinetics and tolerance of oral ganciclovir (1987) (85)
- Bronchial hyperresponsiveness in normal subjects during attenuated influenza virus infection. (1991) (84)
- Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS. (1988) (80)
- Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis (1988) (80)
- Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. (2005) (75)
- An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). (2001) (75)
- Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo (2007) (75)
- Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. (2003) (73)
- HIV‐1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV‐1‐infected individuals (1998) (72)
- Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet (1996) (70)
- Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. (1995) (68)
- Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120 (1991) (68)
- The role of valve replacement in the treatment of fungal endocarditis. (1975) (68)
- Live attenuated HIV vaccines: Predicting the tradeoff between efficacy and safety (2001) (67)
- Association of matrix protein of respiratory syncytial virus with the host cell membrane of infected cells (2003) (67)
- Exopolysaccharide production by viridans streptococci in experimental endocarditis (1984) (66)
- Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. (1984) (66)
- Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages. (1996) (66)
- Mutants of influenza virus. (1969) (66)
- Morbidity and mortality of patients with AIDS and first-episode Pneumocystis carinii pneumonia unaffected by concomitant pulmonary cytomegalovirus infection. (1991) (62)
- Evaluation of an interferon inducer in viral respiratory disease. (1972) (62)
- Current research on respiratory viral infections: Fourth International Symposium (2001) (61)
- Antiviral chemotherapy: New directions for clinical application and research (1986) (57)
- Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. (1985) (56)
- Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis (1989) (55)
- Natural Killer Cytotoxicity and Antibody-Dependent Cellular Cytotoxicity of Human Immunodeficiency Virus–Infected Cells by Leukocytes from Human Neonates and Adults (1993) (54)
- Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells. (1990) (53)
- Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection. (1988) (53)
- Enzymatic modification of glycocalyx in the treatment of experimental endocarditis due to viridans streptococci. (1987) (52)
- Comparison of direct immunofluorescence and direct immunoperoxidase procedures for detection of herpes simplex virus antigen in lesion specimens (1983) (48)
- Treatment of cytomegalovirus retinitis in patients with AIDS. (1988) (48)
- Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome (1988) (48)
- Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs, seventh edition (2017) (46)
- Live attenuated HIV vaccines: a proposal for further research and development. (2000) (45)
- Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo. (1988) (44)
- DECLINING PREVALENCE OF KAPOSI'S SARCOMA IN HOMOSEXUAL AIDS PATIENTS PARALLELED BY FALL IN CYTOMEGALOVIRUS TRANSMISSION (1988) (44)
- Specific Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Integration in Cell Culture: Putative Inhibitors of HIV-1 Integrase (2001) (43)
- Role of cardiac catheterization in infective endocarditis. (1977) (41)
- Health Policy Modeling: Epidemic Control, HIV Vaccines, and Risky Behavior (2001) (41)
- Respiratory Syncytial Virus Neutralizing Activity in Nasal Secretions Following Natural Infection∗ (1969) (41)
- Annular erosion and pericarditis. Complications of endocarditis of the aortic root. (1972) (40)
- Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages (1997) (39)
- Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS. (1989) (39)
- The acquired immunodeficiency syndrome. Infection control and public health law. (1986) (38)
- Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1. (1995) (37)
- Coreceptor Phenotype of Natural Human Immunodeficiency Virus with Nef Deleted Evolves In Vivo, Leading to Increased Virulence (2002) (36)
- Vaccination with Attenuated Simian Immunodeficiency Virus by DNA Inoculation (2001) (35)
- Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia. (2004) (35)
- Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis. (1988) (35)
- Effects of exopolysaccharide production by viridans streptococci on penicillin therapy of experimental endocarditis. (1985) (34)
- Management of the HIV-infected patient (1996) (33)
- Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus. (1988) (32)
- Interferon Therapy for Condylomata Acuminata (1987) (31)
- HIV infection and aging of the innate immune system. (2011) (31)
- Pneumocystis carinii, Toxoplasma gondii, Cytomegalovirus and the compromised host. (1979) (30)
- Evaluation of influenza virus mutants for possible use in a live virus vaccine. (1969) (28)
- Comparative assessment of antiretrovirals in human monocyte‐macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus (1989) (27)
- Evaluation of Low Temperature Grown Influenza A2/Hong Kong Virus in Volunteers (1971) (27)
- Human immunodeficiency virus-infected monocyte-derived macrophages express surface gp120 and fuse with CD4 lymphoid cells in vitro: a possible mechanism of T lymphocyte depletion in vivo. (1992) (27)
- Passive immunotherapy for encephalitis caused by herpes simplex virus. (1986) (25)
- Once-daily ceftriaxone for skin and soft tissue infections (1985) (25)
- Adverse Effects of Antiretroviral Drugs on HIV-1-Infected and -Uninfected Human Monocyte-Derived Macrophages (2006) (25)
- Prolonged pancytopenia due to combined ganciclovir and zidovudine therapy. (1988) (24)
- Effects of Sendai virus infection on function of cultured mouse alveolar macrophages. (1979) (22)
- Cefuroxime axetil for treatment of uncomplicated gonorrhea (1986) (21)
- Multiple heparin binding domains of respiratory syncytial virus G mediate binding to mammalian cells (2003) (21)
- Serratia Endocarditis: A Follow-up Report (1980) (20)
- Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes (1989) (20)
- Serratia endocarditis. A follow-up report. (1980) (19)
- HIV replication in chronically infected macrophages is not inhibited by the Tat inhibitors Ro‐5‐3335 and Ro‐24‐7429 (1994) (19)
- Acyclovir prevents reactivation of herpes simplex labialis in skiers (1990) (19)
- Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis (1981) (19)
- Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin (1987) (18)
- Large-scale serological screening for cytomegalovirus antibodies in homosexual males by enzyme-linked immunosorbent assay (1984) (16)
- Sequence and structure relatedness of matrix protein of human respiratory syncytial virus with matrix proteins of other negative-sense RNA viruses. (2004) (16)
- Modified semliki forest virus expression vector that facilitates cloning. (1997) (16)
- Failure of adjunctive cytomegalovirus intravenous immune globulin to improve efficacy of ganciclovir in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: a phase 1 study (1990) (16)
- Inhibition of platelet binding and aggregation by streptococcal exopolysaccharide. (1993) (16)
- Human immunodeficiency virus: novel enzyme-linked immunoassays for quantitation of envelope glycoprotein 120. (1991) (16)
- Coresistance to Zidovudine and Foscarnet Is Associated with Multiple Mutations in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase (1998) (15)
- Dapsone as a single agent is suboptimal therapy for Pneumocystis carinii pneumonia. (1991) (14)
- Preventive and therapeutic strategies for respiratory syncytial virus infection. (2001) (14)
- Screening for inhibitors of HIV gp120-CD4 binding using an enzyme-linked immunoabsorbent assay. (1993) (14)
- Kucers' The Use of Antibiotics (2010) (13)
- Effects of L3T4+ lymphocyte depletion on acute murine cytomegalovirus infection. (1989) (12)
- Quantitative Assessment of Intra-Patient Variation in CD4+ T Cell Counts in Stable, Virologically-Suppressed, HIV-Infected Subjects (2015) (12)
- In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria (1981) (11)
- Short Communication: Impaired Fitness of Foscarnet-Resistant Strains of Human Immunodeficiency Virus Type 1 (1998) (11)
- Comparison of cefonicid and cefazolin for treatment of soft-tissue infections. (1984) (11)
- Detection and subgrouping of respiratory syncytial virus directly from nasopharyngeal aspirates. (1997) (11)
- Ceftizoxime compared with cefamandole for treatment of soft tissue infections. (1982) (11)
- Development of cytomegalovirus (CMV) retinitis in a patient with AIDS during ganciclovir therapy for CMV colitis. (1987) (11)
- Protein-protein interactions in RSV assembly: potential targets for attenuating RSV strains. (2012) (11)
- An unusual case of HIV virologic failure during treatment with boosted atazanavir. (2013) (10)
- Effects of selective depletion of L3T4+ T-lymphocytes on herpes simplex virus encephalitis. (1989) (10)
- Effectiveness of aztreonam for the treatment of gonorrhea (1985) (10)
- Ceftizoxime for treatment of gonorrhoea. (1982) (10)
- Antiviral Chemotherapy 4 (1996) (9)
- Experimental reproduction of endocarditis with Pasteurella gallinarum in mature leghorn chickens. (1995) (9)
- Comparison of nosocomial infections due to Staphylococcus aureus and enterococci in a general hospital. (1987) (9)
- AIDS and AIDS-related infections: Current strategies for Prevention and therapy: edited by Adrian Bint and John Oxford, Academic Press, 1989. £12.50 (v + 137 pages) ISBN 12 099200 0 (1990) (9)
- Prevention and treatment of respiratory syncytial virus infections. (1999) (8)
- Sextuplibacterial endocarditis: a new world's record? (1988) (7)
- C4B Deficiency: A Risk Factor for Bacteremia with Encapsulated Organisms (1990) (6)
- Comparative recovery of cytomegalovirus from saliva, mucolysed induced sputum, and bronchoalveolar lavage fluid from patients at risk for or with acquired immunodeficiency syndrome (1989) (6)
- Respiratory syncytial virus G glycoprotein expressed using the Semliki Forest virus replicon is biologically active (1999) (6)
- Chemotherapy for herpes simplex virus infections. (1985) (6)
- In vivo replication kinetics of a nef-deleted strain of HIV-1. (2005) (6)
- Infective endocarditis. Is cardiac catheterization usually needed before cardiac surgery? (1984) (6)
- Impaired fitness of foscarnet-resistant strains of human immunodeficiency virus type 1. (1998) (6)
- Aerosolized pentamidine and Pneumocystis carinii pneumonia. (1989) (5)
- Varicella-zoster vaccine: The bad news may be good (2000) (5)
- Amantadine and rimantadine (2017) (5)
- Respiratory Syncytial Virus Matrix Protein-Chromatin Association Is Key to Transcriptional Inhibition in Infected Cells (2021) (5)
- Treatment of opportunistic infections. (1990) (5)
- What can be done against the further spread of AIDS? (1987) (5)
- Infectivity of wild-type and deleted proviral SIV DNA. (2001) (4)
- Cytomegalovirus infection. (1988) (4)
- Opportunistic Infections in Patients with the Acquired Immunodeficiency Syndrome (1989) (4)
- Listeria monocytogenes peritonitis in an HIV-infected patient. (2017) (4)
- Management of respiratory syncytial virus infections. (1996) (4)
- Response: Attenuated HIV Vaccine: Caveats (1996) (4)
- Testing for herpes simplex virus type 2: full-steam ahead? (2000) (3)
- Expression and characterisation of the ovine respiratory syncytial virus (ORSV) G protein for use as a diagnostic reagent. (1999) (3)
- Pulmonary Complications of the Acquired Immunodeficiency Syndrome: An Update (2015) (3)
- Lack of evidence of occult human immunodeficiency virus in seronegative individuals at very high risk of infection (1991) (3)
- The Future of Antiviral Chemotherapy (1988) (3)
- Refractory raoultella planticola peritonitis in an HIV positive patient (2016) (3)
- Genital herpes simplex infections: some therapeutic dilemmas. (2003) (3)
- Mediators of fusion between HIV-infected macrophages and lymphoid cells. (1991) (2)
- Other virus infections in AIDS. II. Herpes simplex virus. (1989) (2)
- Antiviral Chemotherapy 5 (1999) (2)
- Managing HIV. Part 3: Mechanisms of disease. 3.1 Structure and function of HIV. (1996) (2)
- Genital herpes and genital human papillomavirus infection (1995) (2)
- 3.1 Structure and function of HIV (1996) (2)
- Role of Bronchoalveolar Lavage in the Diagnosis of Pneumonia (2017) (1)
- Principles of antimicrobial use (2017) (1)
- Treatment of herpes simplex and varicella zoster infections. (1994) (1)
- Massive rectal bleeding in pregnancy: a case report. (1995) (1)
- Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4. (1996) (1)
- Immunotherapy and immunoprophylaxis of respiratory syncytial virus infections (1995) (1)
- Management of Genital Herpes Defining the Role of Valaciclovir (2004) (1)
- Overview of the Australasian Society for HIV Medicine 12th Annual Conference (2001) (1)
- Treatment of Gonorrhea with First- and Second‐generation Cephalosporins and Other New β-Lactam Antibiotics (1986) (1)
- Patterns of susceptibility to acyclovir and foscarnet in 209 herpes simplex virus hsv isolates (1992) (1)
- Process for the manufacture of anticonvulsant derivatives of topiramate (2004) (1)
- Hemodynamic selection of patients with bacterial endocarditis for valve replacement. (1974) (0)
- The Future of Antiviral Chemotherapy (1988) (0)
- Conference on HIV, lentiviruses, and the monocyte-macrophage. November 9-10, 1989, San Francisco, California. (1990) (0)
- Investigational antiviral drugs (2017) (0)
- RSV research is now close to providing solutions to RSV infection. (2012) (0)
- AIDS 1990. Clinical treatment: overview. (1990) (0)
- Clinical Features and Growth Factors in Infants Exposed to Alcohol in Ureto (1999) (0)
- Mechanisms ofPlatelet Aggregation byViridans GroupStreptococci (1987) (0)
- The acquired immune deficiency syndrome: An international health problem of increasing importance (1984) (0)
- Chromosome studies in women who had used oral contraceptives and in their progeny. (Abstract only) (1976) (0)
- Newer antibiotics - and new ways to use older ones (1984) (0)
- Procede de preparation de derives de topiramate anticonvulsifs (2004) (0)
- Discontinued herpesvirus agent: Vidarabine (2017) (0)
- Virulence Evolves In Vivo , Leading to Increased Immunodeficiency Virus with Nef Deleted Coreceptor Phenotype of Natural Human (2002) (0)
- Biology of HIV-1 and HIV-2 infections (2001) (0)
- Response from Deacon et al. (1996) (0)
- TREATMENT AND SUPPRESSION OF CMV INFECTIONS IN HIV-INFECTED PATIENTS (1994) (0)
- Ganciclovir for cytomegalovirus retinitis. (1989) (0)
- Comparative Recovery ofCytomegalovirus fromSaliva, Mucolysed Induced Sputum, andBronchoalveolar LavageFluid fromPatients atRiskfororwithAcquired Immunodeficiency Syndrome (1989) (0)
- Prevention andTreatment ofExperimental HerpesSimplex Virus Encephalitis withHumanImmuneSerumGlobulin (1987) (0)
- Chemotherapy of herpesvirus infections: Present successes and future hopes (1985) (0)
- Temperature-Sensitive Mutants of Influenza Virus. Tissue Culture and in Experimental Animals I. Behavior in (1971) (0)
- Antiviral chemotherapy 4 : new directions for clincal application and rersearch (2017) (0)
- Terrence Inhibitors of HIV-1 Integrase Integration in Cell Culture : Putative Immunodeficiency Virus Type 1 ( HIV-1 ) Specific Inhibition of Human (2001) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John H. Mills?
John H. Mills is affiliated with the following schools:
